$VRAX Breaking Out! 🚀 Up 16% Premarket! 🔹 Virax Biolabs is catching fresh momentum after a massive regular-session move 📈 🔹 Company focuses on immune-respon

$VRAX Breaking Out! 🚀 Up 16% Premarket! 🔹 Virax Biolabs is catching fresh momentum after a massive regular-session move 📈 🔹 Company focuses on immune-response diagnostics and viral disease testing ⚕️ 🔹 Recent focus includes T-cell dysfunction, post-acute infection syndromes, and immune profilin…